Yasons Chemex Care (NSE:YCCL) Research & Development: ₹0.0 Mil (TTM As of Mar. 2023)


NSE:YCCL Yasons Chemex Care Ltd NSE:YCCL
17 GF Score
Price ₹9.80
View Full Analysis

What is Yasons Chemex Care Research & Development?

Yasons Chemex Care NSE:YCCL 17 Research & Development is ₹0.0 Mil as of Mar. 2023. GuruFocus rates NSE:YCCL with a GF Score™ of 17/100.

Research & Development is the aggregate amount of research and development expenses during the year. Yasons Chemex Care's Research & Development for the six months ended in Mar. 2023 was ₹0.0 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Mar. 2023 was ₹0.0 Mil.

Yasons Chemex Care  (NSE:YCCL) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Yasons Chemex Care Research & Development Related Terms

Yasons Chemex Care Research & Development Historical Data

* Premium members only.

The historical data trend for Yasons Chemex Care's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Yasons Chemex Care Research & Development Chart

Yasons Chemex Care Annual Data
Trend Mar19 Mar20 Mar21 Mar22 Mar23
Research & Development
0.00 0.00 0.00 0.00 0.00

Yasons Chemex Care Semi-Annual Data
Mar19 Mar20 Mar21 Mar22 Mar23
Research & Development 0.00 0.00 0.00 0.00 0.00
NSE:YCCL
17GF Score
Yasons Chemex Care Ltd NSE:YCCL
Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Yasons Chemex Care Research & Development Calculation

This is the expense the company spent on research and development.

For stock reported annually, GuruFocus uses latest annual data as the TTM data. Research & Development for the trailing twelve months (TTM) ended in Mar. 2023 was ₹0.0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of ₹0.0 Mil mean?
Yasons Chemex Care (NSE:YCCL) has a Research & Development of ₹0.0 Mil as of Mar. 2023. Research and development expense is the total cost for research and development activities. View historical data on Yasons Chemex Care and its competitors.
Is Yasons Chemex Care's Research & Development too high?
Yasons Chemex Care's current Research & Development is ₹0.0 Mil. Overall, Yasons Chemex Care has a GF Score™ of 17/100, reflecting its overall financial health beyond just this single metric.
How does Yasons Chemex Care's Research & Development compare to LIN and SHW?
Yasons Chemex Care's Research & Development of ₹0.0 Mil can be compared against companies in the Chemicals industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for a Chemicals company?
A good Research & Development depends on the Chemicals industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on Yasons Chemex Care and its competitors. Yasons Chemex Care's current Research & Development is ₹0.0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Yasons Chemex Care stock overvalued right now?
Yasons Chemex Care (NSE:YCCL) has a current Research & Development of ₹0.0 Mil. The current Research & Development is ₹0.0 Mil. Yasons Chemex Care's overall GF Score™ is 17/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For Yasons Chemex Care (NSE:YCCL), the current Research & Development is ₹0.0 Mil as of Mar. 2023. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Yasons Chemex Care Business Description

Address 132ft Ring Road, 4th floor, 412 Sigma Icon-1, Opposite Medilink Hospital, Satellite, Ahmedabad, GJ, IND, 380015
Yasons Chemex Care Ltd is engaged in manufacturing dyes & pigment paste, IMCG, and FMCG products. The IMCG products of the company includes Textile dyes, pigments and paints. The Company also manufactures a wide range of pigment paste from various chemicals. Within FMCG it manufactures or packages products such as hair oil, perfumes & deodorant, handmade soap, sanitizer, etc., under its brand name PLXO.
17GF Score

Get the complete analysis for NSE:YCCL

Research & Development is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹9.80
Price